Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety

PURPOSE: To evaluate the efficacy of cytokine-induced killer (CIK) cell therapy in the treatment of hepatocellular carcinoma. MATERIALS AND METHODS: Randomized phase II and III trials on CIK cell-based therapy were identified by electronic searches using a combination of "hepatocellular carcino...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ma, Yue, Xu, Ying-Chun, Tang, Lei, Zhang, Zan, Wang, Jian, Wang, Hong-Xia
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2012
Schlagworte:
Methodology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3514101/
https://ncbi.nlm.nih.gov/pubmed/23210562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2162-3619-1-11
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge